|
US2019017035A1
|
|
Methods for modulating cyclic nucleotide-mediated signaling in cardiac myocytes and compositions
|
|
CN110573194A
|
|
Microfluidic diffusion devices and systems and methods of making and using the same
|
|
CA3060571A1
|
|
Smart foot position sensor for power wheelchair users, and systems and methods of using same
|
|
US2017296518A1
|
|
Method for diagnosing, preventing, and treating neurological diseases
|
|
US2017071761A1
|
|
Ankle-foot prosthesis for automatic adaptation to sloped walking surfaces
|
|
US2016176930A1
|
|
Mu opioid receptor agonist analogs of the endomorphins
|
|
WO2016014857A1
|
|
Parasympathetic activation by vagus nerve stimulation
|
|
US2015265489A1
|
|
Stability ring
|
|
US2016258573A1
|
|
Exercise machine and method for use in a supine position
|
|
US2015142474A1
|
|
Systems and methods for automated order and notification for patient interventions based on health records
|
|
WO2014066830A1
|
|
Composition and methods for the prevention and treatment of diet-induced obesity
|
|
US2015343048A1
|
|
Attenuated EHEC and clostridial toxins TcdA and TcdB based vaccine for Clostridium difficil associated disease (CDAD)
|
|
US2014066469A1
|
|
Treatment of diseases associated with inflammation
|
|
US2013274628A1
|
|
Systems and methods for the screening and monitoring of inner ear function
|
|
WO2013130672A2
|
|
Improved cancer treatments and diagnostics
|
|
US2014324120A1
|
|
Integrated surface stimulation device for pain management and wound therapy
|
|
US2014197950A1
|
|
Systems and methods for detecting outages in a medical record exchange system
|
|
CA2857419A1
|
|
Method and pulse oximeter apparatus using chemical heating
|
|
US2013109951A1
|
|
System for screening the skin condition of the plantar surface of the feet
|
|
CA2783359A1
|
|
Opioid peptide esters and methods of use
|
